342 related articles for article (PubMed ID: 17051152)
1. The structure of complement C3b provides insights into complement activation and regulation.
Abdul Ajees A; Gunasekaran K; Volanakis JE; Narayana SV; Kotwal GJ; Murthy HM
Nature; 2006 Nov; 444(7116):221-5. PubMed ID: 17051152
[TBL] [Abstract][Full Text] [Related]
2. Structural insights on complement activation.
Alcorlo M; López-Perrote A; Delgado S; Yébenes H; Subías M; Rodríguez-Gallego C; Rodríguez de Córdoba S; Llorca O
FEBS J; 2015 Oct; 282(20):3883-91. PubMed ID: 26250513
[TBL] [Abstract][Full Text] [Related]
3. Structure of C3b in complex with CRIg gives insights into regulation of complement activation.
Wiesmann C; Katschke KJ; Yin J; Helmy KY; Steffek M; Fairbrother WJ; McCallum SA; Embuscado L; DeForge L; Hass PE; van Lookeren Campagne M
Nature; 2006 Nov; 444(7116):217-20. PubMed ID: 17051150
[TBL] [Abstract][Full Text] [Related]
4. Structure of C3b reveals conformational changes that underlie complement activity.
Janssen BJ; Christodoulidou A; McCarthy A; Lambris JD; Gros P
Nature; 2006 Nov; 444(7116):213-6. PubMed ID: 17051160
[TBL] [Abstract][Full Text] [Related]
5. A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism.
Rodriguez E; Nan R; Li K; Gor J; Perkins SJ
J Biol Chem; 2015 Jan; 290(4):2334-50. PubMed ID: 25488663
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
Farries TC; Lachmann PJ; Harrison RA
Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into the central complement component C3.
Janssen BJ; Gros P
Mol Immunol; 2007 Jan; 44(1-3):3-10. PubMed ID: 16875735
[TBL] [Abstract][Full Text] [Related]
9. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
Becherer JD; Alsenz J; Esparza I; Hack CE; Lambris JD
Biochemistry; 1992 Feb; 31(6):1787-94. PubMed ID: 1371073
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
11. Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3.
Li K; Gor J; Perkins SJ
Biochem J; 2010 Oct; 431(1):63-72. PubMed ID: 20666732
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of Kaposica reveals that bridging of MG2 and CUB domains of target protein is crucial for the cofactor activity of RCA proteins.
Gautam AK; Panse Y; Ghosh P; Reza MJ; Mullick J; Sahu A
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12794-9. PubMed ID: 26420870
[TBL] [Abstract][Full Text] [Related]
13. Structure-function relationships of complement receptor type 1.
Krych-Goldberg M; Atkinson JP
Immunol Rev; 2001 Apr; 180():112-22. PubMed ID: 11414353
[TBL] [Abstract][Full Text] [Related]
14. Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b.
van den Bos RM; Pearce NM; Granneman J; Brondijk THC; Gros P
Front Immunol; 2019; 10():2097. PubMed ID: 31552043
[TBL] [Abstract][Full Text] [Related]
15. Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein.
Ahmad M; Raut S; Pyaram K; Kamble A; Mullick J; Sahu A
J Immunol; 2010 Nov; 185(10):6128-37. PubMed ID: 20956343
[TBL] [Abstract][Full Text] [Related]
16. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
[TBL] [Abstract][Full Text] [Related]
17. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.
Pangburn MK; Müller-Eberhard HJ
J Exp Med; 1980 Oct; 152(4):1102-14. PubMed ID: 6903192
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional analysis of a C3b-specific antibody that selectively inhibits the alternative pathway of complement.
Katschke KJ; Stawicki S; Yin J; Steffek M; Xi H; Sturgeon L; Hass PE; Loyet KM; Deforge L; Wu Y; van Lookeren Campagne M; Wiesmann C
J Biol Chem; 2009 Apr; 284(16):10473-9. PubMed ID: 19196712
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2-encoded ORF8 protein possesses complement inhibitory properties.
Kumar J; Dhyani S; Kumar P; Sharma NR; Ganguly S
J Biol Chem; 2023 Mar; 299(3):102930. PubMed ID: 36682494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
